KUR-212

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameKUR-212
Drug Alias NameKUR-212I-020502
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPlatelet-derived growth factor subunit B stimulantsPlatelet-derived growth factor subunit A stimulants
TargetsPlatelet-derived growth factor subunit BPlatelet-derived growth factor subunit A
Therapy Area/IndicationsBurns
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuros Biosurgery Ag
Active IndicationsN/A
Inactive IndicationsBurns

Other Information

ATC CodeN/A
Related LinksN/A